Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,300 shares, a decline of 35.0% from the February 13th total of 2,000 shares. Based on an average daily volume of 13,600 shares, the days-to-cover ratio is currently 0.1 days.
Carl Zeiss Meditec Trading Up 7.4 %
Shares of OTCMKTS:CZMWY opened at $69.73 on Monday. The business’s fifty day moving average price is $57.86 and its two-hundred day moving average price is $61.06. Carl Zeiss Meditec has a fifty-two week low of $46.13 and a fifty-two week high of $133.15.
Carl Zeiss Meditec Dividend Announcement
The firm also recently announced an annual dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.6246 per share. This represents a dividend yield of 1%. The ex-dividend date is Friday, March 28th. Carl Zeiss Meditec’s payout ratio is presently 32.64%.
Analysts Set New Price Targets
Read Our Latest Analysis on Carl Zeiss Meditec
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- What is diluted earnings per share (Diluted EPS)?
- Disney Stock: 4 Key Metrics Validating Its Comeback
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Resilient Investing: 3 Stocks Built to Weather Market Volatility
- What to Know About Investing in Penny Stocks
- Gold Breaks $3,000: What’s Driving the Rally and How to Invest?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.